These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14525878)

  • 1. Taking simvastatin in the morning compared with in the evening: randomised controlled trial.
    Wallace A; Chinn D; Rubin G
    BMJ; 2003 Oct; 327(7418):788. PubMed ID: 14525878
    [No Abstract]   [Full Text] [Related]  

  • 2. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
    McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
    Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of high-intensity statin therapy with simvastatin 80 mg and atorvastatin 80 mg in primary care.
    Meek CL; Reston JD; Ramsbottom T; Pathmanathan H; Viljoen A
    Int J Clin Pract; 2011 Feb; 65(2):120-6. PubMed ID: 21235694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin.
    Lindgren P; Graff J; Olsson AG; Pedersen TJ; Jönsson B;
    Eur Heart J; 2007 Jun; 28(12):1448-53. PubMed ID: 17371782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
    Reckless JP; Henry P; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO; Lis K; Brudi P; Allen C
    Int J Clin Pract; 2008 Apr; 62(4):539-54. PubMed ID: 18266852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of therapy with simvastatin 80 mg and 120 mg in patients with familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Chik G
    Int J Clin Pract; 2001 Dec; 55(10):673-5. PubMed ID: 11777291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial).
    Pedersen TR; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Lindahl C; Szarek M
    Am J Cardiol; 2010 Aug; 106(3):354-9. PubMed ID: 20643245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
    Olsson AG
    Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
    [No Abstract]   [Full Text] [Related]  

  • 14. [What has changed in therapy of vascular patients (role of statins and beta-adrenoblockers)].
    Pokrovskiĭ AV; Goloviuk AL
    Angiol Sosud Khir; 2010; 16(2):7-11. PubMed ID: 21032867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in hypertensive patients without prior cardiovascular disease.
    Foody JM; Joyce AT; Jeffers BW; Liu LZ; Benner JS
    Am J Ther; 2011; 18(2):110-6. PubMed ID: 20216383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).
    Nicholls SJ; Brandrup-Wognsen G; Palmer M; Barter PJ
    Am J Cardiol; 2010 Jan; 105(1):69-76. PubMed ID: 20102893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Say no to the extremes in the debate on lipid reduction].
    Hjemdahl P; Allhammar A; Eklund J; Forslund T; Hulting J; Kahan T; Martinsson A; Malmström R; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
    Lakartidningen; 2011 Sep 7-13; 108(36):1664-5. PubMed ID: 22032007
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

  • 19. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
    Pérez A
    Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585
    [No Abstract]   [Full Text] [Related]  

  • 20. An evaluation of low-dose simvastatin in achieving LDL goal: a retrospective chart review.
    Schnee DM; Bogdanski L; Zaiken K; McCloskey WW
    Manag Care Interface; 2007 May; 20(5):53-7. PubMed ID: 17626594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.